Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

Dec 28, 2007

29777_dirs_2007-12-27_8eae4c18-399f-4c96-a048-7512c480bac5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-12-27

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-12-27 Common shares without par value M 6691 $52.2529 Acquired 151402 Direct
2007-12-27 Common shares without par value M 2286 $43.73 Acquired 153688 Direct
2007-12-27 Common shares without par value S 8977 $57.575 Disposed 144711 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-12-27 Option (right to buy) $52.2529 M 6691 Disposed 2008-02-12 common shares (6691) Direct
2007-12-27 Option (right to buy) $43.73 M 2286 Disposed 2008-02-12 common shares (2286) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 13834 Indirect
Common shares without par value 295 Indirect
Common shares without par value 296 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 26, 2007.

F2: Reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.